Chosa Oncology AB (FRA:W5L)

Market Cap	3.05M
Revenue (ttm)	419.85K +12.0%
Net Income	-516.91K
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0536
Previous Close	0.0538
Day's Range	0.0536 - 0.0536
52-Week Range	0.0528 - 0.1540
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Chosa Oncology AB

Chosa Oncology AB, together with its subsidiaries, engages in developing and commercializing medicines for the treatment of cancer in Sweden and USA. It provides Platin-DRP, a multigene mRNA-based algorithm that predicts a patient’s response to platinum-based chemotherapy; and LiPlaCis, a liposomal formulation of cisplatin, enabling delivery of chemotherapy agent directly to tumor sites. The company was formerly known as Chosa ApS. Chosa Oncology AB was incorporated in 2015 and is based in Malmö, Sweden.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2015
• Country: Sweden
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: W5L

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error